Coya Therapeutics' Alzheimer's Candidate Shows Improved Inflammatory Blood Markers ...
Coya Therapeutics, Inc. (NASDAQ:COYA) announced blood biomarker data from an investigator-initiated, 21-week, double-blind, ...
Coya: Low-Dose IL-2 in AD patients resulted in reduced proinflammatory markers
Coya Therapeutics (COYA) announced encouraging blood biomarker data from an investigator-initiated, 21-week, double-blind, placebo-controlled, ...